QUANTIFICATION OF BONE MARROW DISEASE IN HIGH RISK NEUROBLASTOMA PATIENTS WITH ANTI-GD2 IMMUNOCYTOCHEMISTRY AT DIAGNOSIS AND AT END OF INDUCTION THERAPY - IMPACT ON EVENT-FREE AND OVERALL SURVIVAL. A SIOPEN HIGH RISK STUDY
PEDIATRIC BLOOD & CANCER(2012)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要